◆ 会议时间:2024年9月11-13日
◆ 会议地点:英国 爱丁堡
◆ 会议简介:
2024年第8届世界乳腺癌争议大会(CoBrCa)将于2024年9月11-13日在英国苏格兰爱丁堡举行。本次CoBrCa大会将继续直接处理临床医生在日常实践中面临的关键和有争议的问题,努力找到解决未解决的临床和治疗问题宣的办法。专家们将围绕肿瘤学、外科学、乳腺成像、放射肿瘤学、病理学、重建等主题进行辩论、讨论和演讲。每次讲座结束时,听众将有充足的时间参与讨论。未经许可禁止复制转载摘录镜像本站任何内容-国际医学会议网(lingyuint.com)。
8th World Congress on Controversies in Breast Cancer (CoBrCa2024)
Date:
September 11-13, 2024
Venue:
Edinburgh International Conference Centre (EICC)
Scotland
摘要征文投稿:
Abstract submission deadline: Wednesday, June 5, 2024
点此提交摘要>>>Submit Abstract>>>
Abstract Guidelines
- Abstracts can be submitted online only. Abstracts submitted via email will not be accepted.
- All abstracts must be submitted and presented in English.
- The abstract title is limited to 27 words and should be in CAPS.
- The abstract body may not be longer than 350 words.
- Authors are limited to 15 per abstract.
- Abstracts may include a maximum of one image per abstract (graph/photo) in JPEG format only.
- The text must be formatted in Ariel font size 10. Only the title, abbreviations and acronyms should be in ALL CAPS.
- Abbreviations should be defined.
- Please write concisely and clearly and structure your abstract with the headings:
Problem statement
Methods
Results
Conclusion
- Please ensure that your abstract does not contain spelling, grammar or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done. Linguistic accuracy is the responsibility of the submitter.
- Abstract submissions that do not meet the above noted guidelines may be rejected without review.
- Please include Disclosure of Interest, if any, at the end of the abstract body.
- The Organizing Committee may request additional information about abstracts.
Welcome Letter
The 8th World Congress on Controversies in Breast Cancer (CoBrCa) will take place in Edinburgh, Scotland, UK from September 11-13, 2024. We are pleased to announce that this year the congress will be held in partnership with the UK Association of Breast Surgery (ABS), and we look forward to working together to bring you this novel event.
The 8th CoBrCa Congress will continue to directly address key and controversial issues facing clinicians in their daily practice in an effort to find solutions to unresolved clinical and therapeutic problems.
Experts, from different disciplines, from all over the world will debate, discuss, and present lectures on topics in medical oncology, surgery, breast imaging, radiation oncology, pathology, reconstruction and more. At the end of each lecture, the participants will be provided with ample time to join the discussion.
We look forward to your participation in this innovative scientific event.
Sincerely,
The Organizing Committee
CoBrCa Congress
注册费:
Register for the CoBrCa congress
Fees
|
Early Fee
Until June 11, 2024 |
Late Fee
From June 12 until
September 3, 2024 |
Last Minute Fee
From September 4
and on-site |
Physicians and Scientists (ABS Member) |
£ 430 |
£ 530 |
£ 630 |
Physicians and Scientists (Non-Member) |
£ 550 |
£ 650 |
£ 750 |
Nurses, Registrars, Residents, Fellows,
Allied Health Professionals* (ABS Member) |
£ 200 |
£ 310 |
£ 390 |
Nurses, Registrars, Residents, Fellows,
Allied Health Professionals* (Non-Member) |
£ 250 |
£ 350 |
£ 430 |
Medical Students* |
£ 100 |
£ 100 |
£ 150 |
Fees include: CoBrCa Congress scientific updates, newsletters, access to accepted abstracts, participation in the Congress, participation in the young scientist competition, the CoBrCa Congress e-Book, Congress material, CoBrCa Congress certificate, free access to CoBrCa Congress Networking Reception and catering during official congress breaks (coffee/tea and lunch) as indicated in the congress program. Fees include VAT.
*Nurses, Students, Registrars, Residents, Fellows and Allied Health Professionals must provide proof confirming their status, which can be sent by replying to the registration confirmation email you will receive upon completion of the process.
**Authors of accepted abstracts will receive an extension on the registration deadline if needed
◆ 参会对象:
妇科医生,肿瘤科医生,外科医生,护士,病理学家,放射科医生,临床医生,住院医师,放射肿瘤学家,学生,以及其他相关卫生保健专业人士。
|